Novo scraps two more heart drug trials, further dimming growth beyond obesity ↧ ↧ Novo scraps two more heart drug trials, further dimming growth beyo... Novo Nordisk said on Monday it had halted two additional trials of its experimental cardiovascular drug ziltivekimab, further denting the Danish drugmaker's efforts to diversify beyond its blockbuster obesity and diabetes franchise.
published
Novo scraps two more heart drug trials, further dimming growth beyond obesity ↧
Open the original public source →
Latest documented BWB result
See Billy's timestamped results and follow-through.
Review the latest gains posts, original timestamps, and proof images published by Banking With Billy.
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.